Assessment of Bone Micro-Architecture Using HR-pQCT

Study Overview
=================
Brief Summary
-----------------
In the context of male osteoporosis, we hypothesize that regional changes in trabecular bone, as well as changes in cortical porosity will play a major role, and thus also affect bone strength. In developing therapeutics the response of individual compartments, regional variations post-therapy will have considerable impact on selecting the therapies as well as monitoring response to therapy. This study, a precursor to other therapeutic trials, will lay the ground-work for the future.

Detailed Description
-----------------
We will recruit 80 subjects who will be stratified into groups based on their T-scores. All subjects will be imaged at Baseline and 12 months. Measures of bone micro-architecture in the tibia and radius using peripheral computed tomography, bone strength measures through finite element analysis will be obtained at all time points. DXA measures at the spine, femur and forearm will be obtained as reference measures. In addition whole body DXA scans will be performed for assessment of body composition.

Official Title
-----------------
Non-Invasive Assessment of Bone Micro-architecture and Strength Changes in Men With Osteopenia and Osteoporosis

Conditions
-----------------
Osteoporosis

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Men 50-85 years old Patients must be willing to undergo a DXA scan. Patients should be willing to undergo HRpQCT scan of the radius and tibia. Exclusion Criteria: Inability to tolerate CT scans Use of medications known to impact bone and mineral metabolism: use of a bisphosphonate or teriparatide in the last year or for >12 months ever; current calcitonin; prednisone >5 mg daily or the equivalent glucocorticoid for >10 days in the last 3 months; current testosterone therapy; current thiazolidinedione (TZD); current androgen deprivation therapy; current use of an antiepileptic agent that alters hepatic vitamin D clearance; use of thyroid hormone replacement with current thyroid stimulating hormone <0.1 mIU/L Disease known to affect bone (e.g., primary hyperparathyroidism, Pagets disease, clinically significant liver disease) Illicit drug use or alcohol use >3 drinks/day Serum calcium >10.2 mg/dL or calculated creatinine clearance <30 mL/min Weight >350 pounds (the maximum weight limit of the DXA) Hardware in the lumbar spine History of bilateral hip replacement, or bilateral wrist or ankle fracture

Ages Eligible for Study
-----------------
Minimum Age: 50 Years
Maximum Age: 85 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| osteoporosis and osteopenia<br>Subjects will be stratified based on DXA BMD T-scores. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Measure cross-sectional and longitudinal differences in bone micro-architecture and strength changes in men with BMD T-scores ≤-2.0 and those with T-scores >-1.0. | Trabecular bone micro-architecture as measured by trabecular number, trabecular BMD, and trabecular bone volume fraction (BV/TV). Cortical bone micro-architecture will be assessed by measuring cortical density & thickness and porosity. | 12 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in Compressive biomechanical bone properties from Baseline to 12 months | Calculate the change in compressive biomechanical properties using µ-finite element analysis | 12 months | 
| Association between BMD, bone micro-architecture, compressive biomechanical properties and body composition at all timepoints | Association between BMD, bone micro-architecture, compressive biomechanical properties and body composition at all timepoints using DXA, HR-pQCT, microfinite element analysis. | Baseline and 12 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
osteopenia and osteoporosis